BEXICASERIN

BEXICASERIN

Longboard Pharmaceuticals Stock Soars 51%. It’s Being Bought for $2.6 Billion.

In a significant development in the pharmaceutical industry, Danish company H Lundbeck A/S has agreed to acquire U.S.based Longboard Pharmaceuticals in a $2.6 billion deal. This acquisition has sent Longboard Pharmaceuticals' stock soaring by over 51% in premarket trading, marking one of the most substantial gains in recent market history..

BEXICASERIN

Lundbeck to acquire Longboard Pharmaceuticals in $2.6B deal

A Major Move in the World of Neuroscience and Rare Diseases In a significant development in the pharmaceutical industry, Danish company Lundbeck A/S has announced its intention to acquire U.S..

BEXICASERIN

Why Is Epilepsy Focused Longboard Pharmaceuticals Stock Trading Higher On Monday?

In a significant development that has sent shockwaves through the healthcare sector, Denmarkbased H. Lundbeck A/S has announced its intention to acquire Longboard Pharmaceuticals, Inc. (NASDAQ: LBPH) for $60.00 per share in cash. This acquisition, valued at approximately $2.6 billion in equity and $2..